While young people aged 25-34 years old were the most likely to say an eye test is good value (72%), fewer than half actually ...

Dry age-related macular degeneration (AMD) significantly affects patients' daily activities and quality of life, regardless of visual impairment.

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

As a result, it’s likely the woman – Denise Rodrigue, 68 – will never drive again. “She is recovering from a broken hip, has some cognitive issues, and macular degeneration,” defence lawyer John ...

Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...

Although it was only launched last year, the Kia EV3 has already made a big impact, most recently winning the UK Car of the Year Awards. When the South Korean brand first ventured into all ...

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved Encelto ...

A new fleet of self-driving taxis is ready to hit the streets this year, rolling out first in Las Vegas. The Amazon-backed vehicles are 10 years in the making, and the company says they want to ...

1 Department of Anesthesiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 2 Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Encelto is the first FDA-approved treatment for ...

ENCELTO is the first FDA-approved treatment for MacTel, utilizing encapsulated cell therapy to deliver CNTF to the retina. Neurotech’s ECT platform provides long-term delivery of therapeutic proteins ...